Genetic Test Evaluation

understanding how genetic tests impact patient management

myPath Melanoma (Myriad Genetics)

May 14, 2018

This report evaluates the analytical validity, clinical validity, and clinical utility of the myPath Melanoma test (Myriad Genetics) as an adjunct diagnostic tool to distinguish between benign nevi and malignant melanoma when histopathologic results of a patient are not clear.